companydata.dkBioLean ApS: Financial statements 2025
CVR: 41078219
BioLean ApS (CVR 41078219) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,226,619 and a net result of DKK -11,923 compared with DKK 6,782 the year before. That is a decrease of 4.7% compared with the year before. Equity amounted to DKK 354,328. The solvency ratio was 30.4%. The company had 3 employees in the financial year.
- Gross Profit
- 1,226,619 kr.
- Profit/Loss
- -11,923 kr.
- Equity
- 354,328 kr.
- Total Assets
- 1,166,903 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.2 mio. | -12 t. | 354 t. | 3 |
| 2024 | - | 1.3 mio. | 7 t. | 366 t. | 3 |
| 2023 | - | 2.6 mio. | 132 t. | 359 t. | 3 |
| 2022 | - | 1.6 mio. | 64 t. | 127 t. | 2 |
| 2021 | - | 1.8 mio. | -212 t. | 64 t. | 4 |
Find more companies like BioLean ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
BioLean ApS has published its annual report for 2024. Gross profit came to DKK 1,287,303, and the net result was DKK 6,782.
About BioLean ApS
BioLean ApS is a Danish company of the type Anpartsselskab based in Gørlev, founded in 2020. The company is registered under the industry Computerprogrammering. The management consists of Jesper Bryde-Jacobsen, Laurent Jan Vermue and Maciej Jan Korzepa. The company's owners include Laurent Jan Vermue, Maciej Jan Korzepa and Tomasz Grzegorz Nowak. In 2025, the company reported a gross profit of DKK 1,226,619 and a net result of DKK -11,923 compared with DKK 6,782 the year before. Equity amounted to DKK 354,328.